salicylic acid has been researched along with plx4032 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gómez Fernández, C; Nieto Rodríguez, D; Rueda Carnero, JM | 1 |
Gerami, P; Martini, M; Sorrell, J | 1 |
Arenberger, P; Arenbergerova, M; Fialova, A; Horazdovsky, J; Mrazova, I; Sticova, E | 1 |
3 other study(ies) available for salicylic acid and plx4032
Article | Year |
---|---|
Facial spiny follicular hyperkeratosis induced by vemurafenib.
Topics: Aged; Antineoplastic Agents; Diagnosis, Differential; Face; Female; Humans; Keratosis; Melanoma; Salicylic Acid; Skin; Skin Neoplasms; Treatment Outcome; Urea; Vemurafenib; Warts | 2018 |
Dermatoscopic evolution of dysplastic nevi showing high-grade dysplasia in a metastatic melanoma patient on vemurafenib.
Topics: Dermoscopy; Dysplastic Nevus Syndrome; Humans; Indoles; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Scalp; Skin Neoplasms; Sulfonamides; Vemurafenib | 2012 |
Toxic epidermal necrolysis induced by vemurafenib after nivolumab failure.
Topics: Antineoplastic Agents; Biopsy; Female; Humans; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Nivolumab; Scalp; Skin; Skin Neoplasms; Stevens-Johnson Syndrome; Treatment Failure; Vemurafenib | 2017 |